肝星状细胞
脂肪性肝炎
转录组
生物
脂肪肝
肝损伤
纤维化
肝病
酒精性肝病
病理
癌症研究
细胞生物学
细胞
基因表达
疾病
医学
内科学
内分泌学
肝硬化
生物化学
基因
作者
Zheng Wang,Jingyang Qian,Xiaoyan Lu,Ping Zhang,Rongfang Guo,He Lou,Shuying Zhang,Jihong Yang,Xiaohui Fan
标识
DOI:10.1101/2021.07.06.451396
摘要
ABSTRACT The heterogeneity of liver non-parenchymal cells (NPCs) is essential for liver structure and function. However, the current understanding of liver NPCs, especially in different liver diseases, remains incompletely elucidated. Here, a single-cell transcriptome atlas of 171,814 NPCs from healthy and 5 typical liver disease mouse models, including alcoholic liver disease, nonalcoholic steatohepatitis (NASH), drug-induced liver injury, cholestatic, and ischemia-reperfusion liver injury is constructed. The inter- and intra-group heterogeneity of 12 types (and numerous subtypes) of NPCs involving endothelial cells, hepatic stellate cells (HSCs), neutrophils, T cells, and mononuclear phagocytes (MPs) are summarized. A protective subtype of neutrophils characterized by Chil3 high is validated and found significantly increasing only in drug-induced and cholestatic liver injury models. Transcriptional regulatory network analysis reveals disease-specific transcriptional reprogramming. Metabolic activity analysis indicates that fibrosis is accompanied by increases in glycolysis and retinol metabolism in activated HSCs and MPs. Moreover, we found that cell-cell interactions between cholangiocytes and immune cells contribute more to cholestatic liver fibrosis compared with NASH, while HSCs are more important for NASH fibrosis. Our atlas, together with an interactive website provides a systematic view of highly heterogeneous NPCs and a valuable resource to better understand pathological mechanisms underlying liver diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI